Biopsy core features are poor predictors of adverse pathology in men with grade group 1 prostate cancer
The Journal of Urology Oct 14, 2017
Audenet F, et al. - This trial was formulated in order to detect the predictors of adverse pathology for low-risk prostate cancer (PCa) treated with radical prostatectomy (RP). Furthermore, it contemplated if a threshold number of positive cores could assist in the decision process for active surveillance (AS). With regard to the exclusion of patients with otherwise low-risk PCa on biopsy, from AS based on criteria such as the number of positive cores or maximum cancer involvement of biopsy cores, a little basis was found.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries